Where neuroscience meets the business of medicine.
在脑科学与药物商业之间，寻找答案。
A quarterly research notebook on psychedelic biotechnology, following Compass Pathways and GH Research.
一个关于迷幻药物生物科技的季度研究博客，持续跟踪 Compass Pathways 与 GH Research。
Read the first comparison阅读第一篇比较Can psychedelic medicine move from the laboratory to the clinic?
迷幻药物，能否从实验室走进诊所？
Compass Pathways and GH Research: an initial comparison through five questions.
用五个问题，开始跟踪 Compass Pathways 与 GH Research。
Read article阅读全文The research journal
研究文章
Issue 01 · October 2026第一期 · 2026 年 10 月Compass Pathways: evidence before access
Compass Pathways：从临床证据到患者可及性
COMP360 is closer to a regulatory decision. The commercial delivery question remains open.
COMP360 正在向监管决策推进；商业交付还有问题需要验证。
GH Research: speed before scale
GH Research：短体验，能否带来高效率？
A strong Phase 2b signal needs replication—and a complete picture of the clinic visit.
二期 b 的强信号，需要进一步验证，也需要看清整个就诊流程。
How to read a clinical result
如何读懂一个临床结果
Stage, score, p-value and uncertainty—in plain language.
用简单的话讲清阶段、评分、p 值和不确定性。
Quarterly, not daily.
每季深入一次。
Each update revisits the same five questions. I read primary sources, distinguish reported results from company expectations, and explain what would change my view.
每次更新都回到同样的五个问题。我阅读原始资料，区分已报告结果与公司预期，并解释什么证据会改变我的判断。
Explore the method了解研究方法